Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04AEG
|
|||
Former ID |
DNC007798
|
|||
Drug Name |
3-(2-phenylthiazol-4-yl)quinolin-2(1H)-one
|
|||
Synonyms |
SCHEMBL5463666; CHEMBL240264; BDBM20859; quinolin-2(1H)-one derivative, 17a
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H12N2OS
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=NC(=CS2)C3=CC4=CC=CC=C4NC3=O
|
|||
InChI |
1S/C18H12N2OS/c21-17-14(10-13-8-4-5-9-15(13)19-17)16-11-22-18(20-16)12-6-2-1-3-7-12/h1-11H,(H,19,21)
|
|||
InChIKey |
OANBFUCSFFQVAU-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cyclin-dependent kinase 5 (CDK5) | Target Info | Inhibitor | [1] |
KEGG Pathway | Axon guidance | |||
Alzheimer's disease | ||||
Cocaine addiction | ||||
NetPath Pathway | EGFR1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Panther Pathway | Axon guidance mediated by semaphorins | |||
Pathway Interaction Database | Reelin signaling pathway | |||
Glucocorticoid receptor regulatory network | ||||
Lissencephaly gene (LIS1) in neuronal migration and development | ||||
EPHA forward signaling | ||||
Trk receptor signaling mediated by the MAPK pathway | ||||
Reactome | DARPP-32 events | |||
CRMPs in Sema3A signaling | ||||
Factors involved in megakaryocyte development and platelet production | ||||
WikiPathways | DNA Damage Response | |||
BDNF signaling pathway | ||||
Alzheimers Disease | ||||
Opioid Signalling | ||||
Semaphorin interactions | ||||
Factors involved in megakaryocyte development and platelet production | ||||
Nicotine Activity on Dopaminergic Neurons | ||||
miRNA Regulation of DNA Damage Response |
References | Top | |||
---|---|---|---|---|
REF 1 | Design and synthesis of quinolin-2(1H)-one derivatives as potent CDK5 inhibitors. Bioorg Med Chem Lett. 2007 Oct 1;17(19):5384-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.